Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils

Neuroscience Letters

Volumn 510, Issue 1, 2012, Pages 29-33

  Min, Dongyu ^a   Mao, Xiaoyuan ^a   Wu, Kuncan ^a   Cao, Yonggang ^a   Guo, Feng ^a   Zhu, Shu ^a   Xie, Ni ^a   Wang, Lei ^b   Chen, Tianbao ^b   Shaw, Chris ^b   Cai, Jiqun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CAMK II; CREB; Donepezil; Global cerebral ischemia; Memory; Neuroprotection

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DONEPEZIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL DENSITY; COGNITIVE DEFECT; CONTROLLED STUDY; GERBIL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HISTOPATHOLOGY; LATENT PERIOD; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPATIAL MEMORY; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; BRAIN ISCHEMIA; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL DEATH; COGNITION DISORDERS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; GERBILLINAE; HIPPOCAMPUS; INDANS; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; NEURONS; NEUROPROTECTIVE AGENTS; PIPERIDINES; SIGNAL TRANSDUCTION;

EID: 84862785007     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.064     Document Type: Article

References (32)

1. Acajou S., Sawada K., Kopsas T., Hahira H., Ogura H., Akanke A. Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine. Eur. J. Pharmacol. 2008, 588:189-197.
2. Agrawal R., Tyagi E., Shukla R., Nath C. Effect of insulin and melatonin on acetylcholinesterase activity in the brain of amnesic mice. Behav. Brain Res. 2008, 189:381-386.
3. Alexander M.P. Specific semantic memory loss after hypoxic-ischemic injury. Neurology 1997, 48:165-173.
4. Block F. Global ischemia and behavioural deficits. Prog. Neurobiol. 1999, 58:279-295.
5. Bourtchuladze R., Frenguelli B., Blendy J., Cioffi D., Schutz G., Silva A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79:59-68.
6. Canal C.E., Chang Q., Gold P.E. Intra-amygdala injections of CREB antisense impair inhibitory avoidance memory: role of norepinephrine and acetylcholine. Learn Mem. 2008, 15:677-686.
7. Cao Y., Mao X., Sun C., Zheng P., Gao J., Wang X., Min D., Sun H., Xie N., Cai J. Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res. Bull. 2011, 85:396-402.
8. 2+/calmodulin. J. Biol. Chem. 2010, 285:17930-17937.
9. Fujiki M., Kobayashi H., Uchida S., Inoue R., Ishii K. Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain Res. 2005, 1043:236-241.
10. Gao Y., Gao G., Long C., Han S., Zu P., Fang L., Li J. Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposure. Biochem. Biophys. Res. Commun. 2006, 340:661-667.
11. Gubbins E.J., Gopalakrishnan M., Li J. Alpha 7 nAChR-mediated activation of MAP kinase pathways in PC12 cells. Brain Res. 2010, 1328:1-11.
12. Hamadate N., Yamaguchi T., Sugawara A., Togashi H., Izumi T., Yoshida T., Ohmura Y., Yoshioka M. Liposome-encapsulated hemoglobin ameliorates impairment of fear memory and hippocampal dysfunction after cerebral ischemia in rats. J. Pharmacol. Sci. 2010, 114:409-419.
13. Hu B.R., Fux C.M., Martone M.E., Zivin J.A., Ellisman M.H. Persistent phosphorylation of cyclic AMP responsive element-binding protein and activating transcription factors following transient cerebral ischemia in rat brain. Neuroscience 1999, 89:437-452.
14. Josselyn S.A., Shi C., Carlezon W.A.J., Neve R.L., Nestler E.J., Davis M. Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J. Neurosci. 2001, 21:2404-2412.
15. Jover-Mengual T., Zukin R.S., Etgen A.M. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 2007, 148:1131-1143.
16. Kamat P.K., Tota S., Saxena G., Shukla R., Nath C. Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity. Brain Res. 2010, 1309:66-74.
17. Khateb A., Ammann J., Annoni J.M., Diserens K. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur. Neurol. 2005, 54:39-45.
18. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982, 239:57-69.
19. Kotani S., Yamauchi T., Teramoto T., Ogura H. Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 2006, 142:505-514.
20. Martinez-Penay I., Mouslim C., Akaaboune M. Calcium/calmodulin kinase II-dependent AChR cycling at the mammalian neuromuscular junction in vivo. J. Neurosci. 2010, 30:12455-12465.
21. 2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. J. Neurochem. 1992, 58:1798-1809.
22. Morris R. Developments of a water-maze procedure for studying spatial learning in the rats. J. Neurosci. Methods 1984, 11:47-60.
23. Roman G.C., Kalaria R.N. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol. Aging 2006, 27:1769-1785.
24. Shieh P.B., Hu S.C., Bobb K., Timmusk T., Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998, 20:727-740.
25. Silva A.J., Stevens C.F., Tonegawa S., Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 1992, 257:201-206.
26. Takada Y., Yonezawa A., Kume T., Katsuki H., Kaneko S., Sugimoto H., Akaike A. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J. Pharmacol. Exp. Ther. 2003, 306:772-777.
27. Tohgi H., Abe T., Kimura M., Saheki M., Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J. Neural Transm. 1996, 103:1211-1220.
28. 2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor. J. Biol. Chem. 2010, 285:20675-20682.
29. Winblad B., Engedal K., Soininen H., Verhey F., Waldemar G., Wimo A., Wetterholm A.L., Zhang R., Haglund A., Subbiah P. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001, 57:489-495.
30. 2+/calmodulin-dependent protein kinase II alpha in dendritic spine enlargement, long-term potentiation, and learning. J. Neurosci. 2009, 29:7607-7618.
31. Yamamoto H., Fukunaga K., Lee K., Soderling T.R. Ischemia-induced loss of brain calcium/calmodulin-dependent protein kinase II. J. Neurochem. 1992, 58:1110-1117.
32. Zhou J., Fu Y., Tang X.C., Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation. Neurosci. Lett. 2001, 306:53-56.